Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pediatr Diabetes ; 11(4): 271-8, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19895567

RESUMEN

OBJECTIVE: To evaluate glycaemic targets set by diabetes teams, their perception by adolescents and parents, and their influence on metabolic control. METHODS: Clinical data and questionnaires were completed by adolescents, parents/carers and diabetes teams in 21 international centres. HbA1c was measured centrally. RESULTS: A total of 2062 adolescents completed questionnaires (age 14.4 +/- 2.3 yr; diabetes duration 6.1 +/- 3.5 yr). Mean HbA 1c = 8.2 +/- 1.4% with significant differences between centres (F = 12.3; p < 0.001) range from 7.4 to 9.1%. There was a significant correlation between parent (r = 0.20) and adolescent (r = 0.21) reports of their perceived ideal HbA1c and their actual HbA1c result (p < 0.001), and a stronger association between parents' (r = 0.39) and adolescents' (r = 0.4) reports of the HbA1c they would be happy with and their actual HbA1c result. There were significant differences between centres on parent and adolescent reports of ideal and happy with HbA1c (8.1 < F > 17.4;p < 0.001). A lower target HbA1c and greater consistency between members of teams within centres were associated with lower centre HbA1c (F = 16.0; df = 15; p < 0.001). CONCLUSIONS: Clear and consistent setting of glycaemic targets by diabetes teams is strongly associated with HbA1c outcome in adolescents. Target setting appears to play a significant role in explaining the differences in metabolic outcomes between centres.


Asunto(s)
Diabetes Mellitus/tratamiento farmacológico , Diabetes Mellitus/psicología , Hipoglucemiantes/uso terapéutico , Insulina/uso terapéutico , Adolescente , Glucemia/análisis , Glucemia/efectos de los fármacos , Niño , Estudios Transversales , Femenino , Hemoglobina Glucada/análisis , Humanos , Masculino , Padres/psicología , Guías de Práctica Clínica como Asunto , Resultado del Tratamiento
2.
Diabet Med ; 25(4): 463-8, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18294223

RESUMEN

AIMS: To assess the importance of family factors in determining metabolic outcomes in adolescents with Type 1 diabetes in 19 countries. METHODS: Adolescents with Type 1 diabetes aged 11-18 years, from 21 paediatric diabetes care centres, in 19 countries, and their parents were invited to participate. Questionnaires were administered recording demographic data, details of insulin regimens, severe hypoglycaemic events and number of episodes of diabetic ketoacidosis. Adolescents completed the parental involvement scale from the Diabetes Quality of Life for Youth--Short Form (DQOLY-SF) and the Diabetes Family Responsibility Questionnaire (DFRQ). Parents completed the DFRQ and a Parental Burden of Diabetes score. Glycated haemoglobin (HbA(1c)) was analysed centrally on capillary blood. RESULTS: A total of 2062 adolescents completed a questionnaire, with 2036 providing a blood sample; 1994 parents also completed a questionnaire. Family demographic factors that were associated with metabolic outcomes included: parents living together (t = 4.1; P < 0.001), paternal employment status (F = 7.2; d.f. = 3; P < 0.001), parents perceived to be over-involved in diabetes care (r = 0.11; P < 0.001) and adolescent-parent disagreement on responsibility for diabetes care practices (F = 8.46; d.f. = 2; P < 0.001). Although these factors differed between centres, they did not account for centre differences in metabolic outcomes, but were stronger predictors of metabolic control than age, gender or insulin treatment regimen. CONCLUSIONS: Family factors, particularly dynamic and communication factors such as parental over-involvement and adolescent-parent concordance on responsibility for diabetes care appear be important determinants of metabolic outcomes in adolescents with diabetes. However, family dynamic factors do not account for the substantial differences in metabolic outcomes between centres.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Adolescente , Automonitorización de la Glucosa Sanguínea/métodos , Automonitorización de la Glucosa Sanguínea/psicología , Niño , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/psicología , Femenino , Humanos , Masculino , Relaciones Padres-Hijo , Aceptación de la Atención de Salud , Calidad de Vida/psicología , Encuestas y Cuestionarios , Resultado del Tratamiento
3.
Ugeskr Laeger ; 158(32): 4497-9, 1996 Aug 05.
Artículo en Danés | MEDLINE | ID: mdl-8759382

RESUMEN

A serious allergic reaction after an insect sting is wellknown source for concern and anxiety. Patients with known hypersensitivity to insect stings are usually equipped with an adrenaline self-injection kit by an allergologist. In Denmark a new device for self-medication of adrenaline was approved in 1994, the adrenaline aerosol spray, Adrenalin Medihaler. The article is based on former studies and experiences, related to the usage of an adrenaline aerosol spray for the treatment of anaphylactic reactions after an insect sting. We conclude that adrenaline aerosol treatment should play an important role as emergency treatment for anaphylactic reactions after insect stings, and in most cases can replace the use of adrenalin self-injection kits. Adrenaline aerosol self-treatment could have an important beneficial effect helping to avoid exacerbation of the initial symptoms after insect venom exposition, such as bronchial obstruction and laryngeal oedema.


Asunto(s)
Anafilaxia/tratamiento farmacológico , Epinefrina/administración & dosificación , Mordeduras y Picaduras de Insectos , Simpatomiméticos/administración & dosificación , Aerosoles , Humanos , Mordeduras y Picaduras de Insectos/complicaciones , Mordeduras y Picaduras de Insectos/inmunología , Autoadministración
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA